focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,983.00
Bid: 1,990.00
Ask: 1,991.00
Change: -45.00 (-2.22%)
Spread: 1.00 (0.05%)
Open: 2,030.00
High: 2,034.00
Low: 1,980.00
Prev. Close: 2,028.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 17th Apr 2013 07:20

African Barrick Gold: Deutsche Bank cuts target price from 230p to 173p, while its hold recommendation is reiterated.Ashmore Group: Morgan Stanley raises target price from 395p to 444p and maintains an equal-weight rating.Ashtead Group: Jefferies increases target price from 615p to 690o and reiterates a buy recommendation.Aquarius Platinum: Investec starts with a target price of 45p and a hold recommendation.British American Tabacco: Nomura lowers target price from 4087p to 4012p, while its buy recommendation remains unchanged.Cello Group: Sanlam Securities initiates with a target price of 75p and a buy recommendation.Derwent London: Investec raises target price from 2275p to 2360p and maintains an add rating.Escher Group Holdings: Panmure Gordon takes target price from 410p to 456p and reiterates a buy recommendation.Falkland Islands Hodlings: WH Ireland cuts target price from 480p to 448p retaining a buy recommendation.Fresnillo: Deutsche Bank takes tatget price from 1260p to 1040p and still recommends selling.Fusion IP: HB Markets initiates with a speculative buy.Hargreaves Lansdown: Jefferies increases target price from 1000p to 1150p, while maintaining a buy recommendation.Hays: HSBC Holdings ups target price from 80p to 106p and leaves its neutral rating unaltered.Hikma Pharmaceuticals: Jefferies reduces target price from 1150p to 1040p keeping a buy recommendation. Panmure Gordon cuts target price from 1100p to 1000p, while its buy recommendation remains unchanged.Imperial Tabacco: Nomura cuts target price from 2443p to 2386p and reiterates a reduce rating.Interbulk Group: Westhouse Securities shifts target price from 11p to 10p and keeps a buy recommendation.InterContinental Hotels Group: Barclays downgrades to equal-weight with a target price of 2085p.JD Sports Fashion: Investec increases target price from 830p to 860p staying with its buy recommendation.Legal & General Group: Investec raises target price from 153p to 193p keeping a hold recommendation.Man Group: Canaccord Genuity raises target price to 120p and upgrades from hold to buy.Michael Page: Jefferies cuts target price from 520p to 500p and retains a buy recommendation. JP Morgan reduces target price from 389p to 370p maintaining a neutral rating. Citigroup lowers target price from 440p to 400p, while leaving its neutral rating unchanged. Credit Suisse moves target price from 400p to 360p and stays with an underperform rating. HSBC Holdings takes target price from 450p to 414p and downgrades to neutral.Moneysupermarket.com: Westhouse Securities moves target price from 195p to 210p and upgrades from neutral to add.Randgold Resources: Deutsche Bank cuts target price from 6030p to 5500p, while maintaining a buy recommendation.Rio Tinto: Deutsche Bank reduces target price from 4521p to 4489p keeping a buy recommendation.Sepura: Investec shifts target price from113p to 115p and leaves its buy recommendation unchanged.Smiths News: N+1 Singer moves target price from 164p to 185p, but downgrades to hold.Speedy Hire: Panmure Gordon shifts target price from 56p to 60p maintaining a buy recommendation.Vodafone Group: Deutsche Bank shifts target price from 173p to 180p and maintains a hold recommendation. HSBC Holdings ups target price from 205p to 230p reiterating an overweight rating.
More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.